Profile | GDS2987 / GI_37539476-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | 11.9 | 30 |
GSM215253 | HMVEC_vehicle_rep3 | 11.5 | 37 |
GSM215254 | HMVEC_atorvastatin_rep1 | 16.4 | 40 |
GSM215282 | HMVEC_atorvastatin_rep3 | 1.5 | 4 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 3.4 | 7 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 40.5 | 54 |
GSM215294 | HMVEC_SLx2119_rep1 | 8.2 | 29 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 33.8 | 46 |
GSM215298 | PASMC_vehicle_rep2 | 53.3 | 61 |
GSM215310 | PASMC_vehicle_rep3 | 7.9 | 13 |
GSM215311 | PASMC_atorvastatin_rep1 | 22 | 37 |
GSM215312 | PASMC_atorvastatin_rep2 | 8.6 | 14 |
GSM215313 | PASMC_atorvastatin_rep3 | 20 | 29 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 21.7 | 35 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 30.4 | 50 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 62.1 | 67 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 36.3 | 54 |
GSM215329 | PASMC_SLx2119_rep3 | 26.9 | 46 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | ||
GSM215332 | Fibroblasts_vehicle_rep3 | 9.1 | 30 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 5.8 | 16 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 5.5 | 16 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | ||
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 14.9 | 44 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 7.2 | 23 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 2.8 | 8 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 11 | 32 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 15 | 39 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 40.5 | 64 |